U.S. Attorneys General File Complaint Against Generic Drugmakers

A coalition of 51 attorneys general in the U.S. filed an antitrust complaint in federal court alleging that key individual executives and manufacturers of dermatological, generic drugs engaged in a widespread conspiracy to artificially inflate and manipulate prices, reduce competition for generic drugs sold across the country.

• The antitrust complaint filed by AGs including Letitia James named as defendants 26 generic, dermatological drug manufacturers and 10 individual executives at these companies
• The complaint alleges broad, coordinated, and systematic antitrust violations, price-fixing, market allocating, and the rigging of bids for more than 80 different topical, generic drugs
• From at least 2007 ...